HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

BACKGROUND: Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer that may progress to invasive cancer. Identification of factors that predict recurrence and distinguish DCIS from invasive recurrence would facilitate treatment recommendations. We examined the prognostic value of ni...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Rakovitch, E, Nofech-Mozes, S, Hanna, W, Narod, S, Thiruchelvam, D, Saskin, R, Spayne, J, Taylor, C, Paszat, L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2012
Aiheet:
Molecular Diagnostics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3304413/
https://ncbi.nlm.nih.gov/pubmed/22361634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.41
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia